148 related articles for article (PubMed ID: 35864733)
1. Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Sadeghzadeh F; Ziaratnia AS; Homayouni Tabrizi M; Torshizi GH; Alhajamee M; Khademi D
J Biomater Sci Polym Ed; 2023 Jan; 34(1):1-17. PubMed ID: 35864733
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
Rahmati A; Homayouni Tabrizi M; Karimi E; Zarei B
J Biomater Sci Polym Ed; 2022 Jul; 33(10):1289-1307. PubMed ID: 35260045
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of folic acid-conjugated chitosan-coated PLGA nanoparticles for targeted delivery of
Homayouni Tabrizi M
Nanotechnology; 2022 Sep; 33(49):. PubMed ID: 36121718
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of designed PLGA-arctiin nanoparticles modified with folic acid and chitosan on colon cancer cells.
Alhadidi MHA; Tabrizi MH; Ghobeh M
Biotechnol Appl Biochem; 2024 Feb; 71(1):72-80. PubMed ID: 37817403
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Lecithin-Chitosan-Folic Acid Nanoparticles as Nanocarriers of Allicin for In Vitro Controlled Release and Anticancer Effects.
Hashemy SI; Amiri H; Hosseini H; Sadeghzadeh F; Jaseem MMM; Tabrizi MH
Appl Biochem Biotechnol; 2023 Jul; 195(7):4036-4052. PubMed ID: 36652093
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin.
Govindarasu M; Abirami P; Alharthi SS; Thiruvengadam M; Rajakumar G; Vaiyapuri M
Biotechnol Appl Biochem; 2022 Dec; 69(6):2387-2398. PubMed ID: 35020231
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
8. Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Ghafaripour H; Homayouni Tabrizi M; Karimi E; Barati Naeeni N
IET Nanobiotechnol; 2023 Jul; 17(5):425-437. PubMed ID: 37191102
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells.
Farhadi A; Homayouni Tabrizi M; Sadeghi S; Vala D; Khosravi T
J Biomater Sci Polym Ed; 2023 Feb; 34(3):315-333. PubMed ID: 36063019
[TBL] [Abstract][Full Text] [Related]
10. Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity.
Al-Fatlawi INAA; Pouresmaeil V; Davoodi-Dehaghani F; Pouresmaeil A; Akhtari A; Tabrizi MH
BMC Biotechnol; 2024 Apr; 24(1):18. PubMed ID: 38600497
[TBL] [Abstract][Full Text] [Related]
11. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract][Full Text] [Related]
12. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
13. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
14. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J
Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment.
Al-Nemrawi NK; Altawabeyeh RM; Darweesh RS
J Pharm Sci; 2022 Feb; 111(2):485-494. PubMed ID: 34728172
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-chitosan coated stylosin nanostructured lipid carriers: fabrication,
Sadeghi S; Homayouni Tabrizi M; Farhadi A
J Biomater Sci Polym Ed; 2023 Apr; 34(6):791-809. PubMed ID: 36345914
[TBL] [Abstract][Full Text] [Related]
19. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
20. New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles.
Şenel B; Öztürk AA
Drug Dev Ind Pharm; 2019 Nov; 45(11):1835-1848. PubMed ID: 31491363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
